Literature DB >> 9223157

Evidence that cellular immune responses to soluble and membrane associated antigens are independently regulated during human schistosomiasis mansoni.

L M Bahia-Oliveira1, A J Simpson, L F Alves-Oliveira, C Carvalho-Queiroz, A M Silveira, I R Viana, J R Cunha-Melo, P Hagan, G Gazzinelli, R Correa-Oliveira.   

Abstract

We have made a comparative analysis of human cellular and antibody responses to membrane associated adult worm antigens (Mb-A), soluble adult worm antigens (SWAP) and soluble egg antigens (SEA) derived from Schistosoma mansoni. Chronically infected patients with the intestinal (I) and hepatosplenic (HS) forms of the disease as well as non-infected putative immune 'endemic normals' (EN), were studied. We observed that the cellular responses, of individuals, to the two adult worm preparations, SWAP and Mb-A, may be distinct and can be related to the occurrence of resistance or pathology. The resistant group (EN) presented higher levels of both cellular proliferation, and IFN-gamma production, in response to Mb-A as compared with SWAP whereas HS individuals presented higher levels of cellular proliferation to SWAP as compared with Mb-A. Individuals with intestinal disease had similar levels of proliferation to both antigens. The response to SEA by all groups was generally similar, and not predictive of any clinical form. The specific antibody response to the three antigens were in general higher among infected patients than in resistant EN individuals. These results support the hypothesis that the response to adult worm antigens may be pivotal in determining both the development of resistance and severity of disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9223157     DOI: 10.1046/j.1365-3024.1996.d01-49.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  8 in total

1.  Human immune responses to Schistosoma mansoni vaccine candidate antigens.

Authors:  A Ribeiro de Jesus; I Araújo; O Bacellar; A Magalhães; E Pearce; D Harn; M Strand; E M Carvalho
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

2.  Differential antigen-stimulated proliferation of human mononuclear cells by recombinant Schistosoma japonicum antigens in a Chinese population.

Authors:  G J Waine; W Yang; A G Ross; Y S Li; A C Sleigh; B H Kalinna; J C Scott; D Mazzer; Y Li; D P McManus
Journal:  Clin Exp Immunol       Date:  1998-04       Impact factor: 4.330

3.  Studies on parasitologic and haematologic activities of an enaminone derivative of 4-hydroxyquinolin-2(1H)-one against murine schistosomiasis mansoni.

Authors:  Amal M El-Shennawy; Amira H Mohamed; Mohamed Abass
Journal:  MedGenMed       Date:  2007-01-23

4.  Cytokine secretion profile associated with periportal fibrosis in S. mansoni-infected Egyptian patients.

Authors:  Roba M Talaat; Azza I El-Bassiouny; Ahmed M Osman; Magdy Yossif; Ragia Charmy; Maged M Al-Sherbiny
Journal:  Parasitol Res       Date:  2007-02-25       Impact factor: 2.289

Review 5.  Current status of vaccines for schistosomiasis.

Authors:  Donald P McManus; Alex Loukas
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

6.  Cross-reactivity of Schistosoma mansoni cytosolic superoxide dismutase, a protective vaccine candidate, with host superoxide dismutase and identification of parasite-specific B epitopes.

Authors:  Claudia Carvalho-Queiroz; Rosemary Cook; Ching C Wang; Rodrigo Correa-Oliveira; Nicola A Bailey; Nejat K Egilmez; Edith Mathiowitz; Philip T LoVerde
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

7.  An immunomics approach to schistosome antigen discovery: antibody signatures of naturally resistant and chronically infected individuals from endemic areas.

Authors:  Soraya Gaze; Patrick Driguez; Mark S Pearson; Tiago Mendes; Denise L Doolan; Angela Trieu; Donald P McManus; Geoffrey N Gobert; Maria Victoria Periago; Rodrigo Correa Oliveira; Fernanda C Cardoso; Guilherme Oliveira; Rie Nakajima; Al Jasinskas; Chris Hung; Li Liang; Jozelyn Pablo; Jeffrey M Bethony; Philip L Felgner; Alex Loukas
Journal:  PLoS Pathog       Date:  2014-03-27       Impact factor: 6.823

8.  Stage-specific immune responses in human Necator americanus infection.

Authors:  S M Geiger; I R Caldas; B E Mc Glone; A C Campi-Azevedo; L M De Oliveira; S Brooker; D Diemert; R Corrêa-Oliveira; J M Bethony
Journal:  Parasite Immunol       Date:  2007-07       Impact factor: 2.280

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.